HealthcareNasdaqsmall
Institutional-grade research for retail investors
SEC EDGAR: CIK 1213809DYAI stock profile & AI dashboard →

13F Pro Quality Score

25.1/100

Rank #2,673 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

DYAI Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for DYADIC INTERNATIONAL INC (DYAI), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores DYAI at 25.1/100 on a 32-signal composite quality model, placing it at rank #2,673 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), DYADIC INTERNATIONAL INC reports quarterly revenue of $961.1K, net income of $-2.1M. Top institutional holders of DYAI by reported 13-F value include VANGUARD CAPITAL MANAGEMENT, CHAPIN DAVIS, APIS CAPITAL ADVISORS, based on the most recent SEC filings. DYAI trades on the Nasdaq exchange and files with the SEC under CIK 1213809. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate DYAI daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for DYADIC INTERNATIONAL INC directly from SEC EDGAR. DYADIC INTERNATIONAL INC's 13F Pro composite quality score has ranged between 17 and 25 since 2026, currently 25.1 — a stable long-term trajectory across 8 quarterly and live scoring snapshots.

Revenue

Q2 2026

$961.1K

Net Income

Q2 2026

$-2.1M

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

-11.6% YoY
$3.1MFY 2025
FY22 $2.9MFY23 $2.9MFY24 $3.5MFY25 $3.1M

Net Income

-26.8% YoY
$-7.4MFY 2025
FY22 $-9.7MFY23 $-6.8MFY24 $-5.8MFY25 $-7.4M

Operating Income

-21.9% YoY
$-7.2MFY 2025
FY22 $-10.2MFY23 $-8.2MFY24 $-5.9MFY25 $-7.2M

EPS (Diluted)

-15.0% YoY
$-0.23FY 2025
FY22 FY23 FY24 $-0.20FY25 $-0.23

Total Assets

+0.2% YoY
$9.9MFY 2025
FY22 $13.7MFY23 $8.2MFY24 $9.9MFY25 $9.9M

Op. Cash Flow

-43.5% YoY
$-5.7MFY 2025
FY22 $-8.1MFY23 $-6.7MFY24 $-4.0MFY25 $-5.7M

Get alerted when DYAI's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for DYADIC INTERNATIONAL INC including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of DYAI

Put DYAI on your watchlist

Track score changes the day DYADIC INTERNATIONAL INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is DYAI a good stock to buy?

13F Pro's AI-powered analysis of DYADIC INTERNATIONAL INC (DYAI) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for DYAI are available on the DYAI stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. DYAI is classified as a small company.

Which hedge funds own DYAI?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling DYAI. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of DYADIC INTERNATIONAL INC's investment landscape.